1. Home
  2. STRO vs GRAF Comparison

STRO vs GRAF Comparison

Compare STRO & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • GRAF
  • Stock Information
  • Founded
  • STRO 2003
  • GRAF 2021
  • Country
  • STRO United States
  • GRAF United States
  • Employees
  • STRO N/A
  • GRAF N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • GRAF
  • Sector
  • STRO Health Care
  • GRAF
  • Exchange
  • STRO Nasdaq
  • GRAF NYSE
  • Market Cap
  • STRO 77.7M
  • GRAF 294.4M
  • IPO Year
  • STRO 2018
  • GRAF 2024
  • Fundamental
  • Price
  • STRO $0.76
  • GRAF $10.46
  • Analyst Decision
  • STRO Hold
  • GRAF
  • Analyst Count
  • STRO 7
  • GRAF 0
  • Target Price
  • STRO $3.97
  • GRAF N/A
  • AVG Volume (30 Days)
  • STRO 1.4M
  • GRAF 4.8K
  • Earning Date
  • STRO 08-12-2025
  • GRAF 01-01-0001
  • Dividend Yield
  • STRO N/A
  • GRAF N/A
  • EPS Growth
  • STRO N/A
  • GRAF N/A
  • EPS
  • STRO N/A
  • GRAF 0.32
  • Revenue
  • STRO $66,434,000.00
  • GRAF N/A
  • Revenue This Year
  • STRO N/A
  • GRAF N/A
  • Revenue Next Year
  • STRO N/A
  • GRAF N/A
  • P/E Ratio
  • STRO N/A
  • GRAF $32.47
  • Revenue Growth
  • STRO N/A
  • GRAF N/A
  • 52 Week Low
  • STRO $0.52
  • GRAF $9.03
  • 52 Week High
  • STRO $5.17
  • GRAF $11.02
  • Technical
  • Relative Strength Index (RSI)
  • STRO 44.98
  • GRAF N/A
  • Support Level
  • STRO $0.67
  • GRAF N/A
  • Resistance Level
  • STRO $0.87
  • GRAF N/A
  • Average True Range (ATR)
  • STRO 0.08
  • GRAF 0.00
  • MACD
  • STRO -0.01
  • GRAF 0.00
  • Stochastic Oscillator
  • STRO 34.81
  • GRAF 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

Share on Social Networks: